Joint Projects Face Limits

An agreement between the U.S. and the U.K. on funding international collaborations is subject to political restrictions.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, HELLERICKThe National Science Foundation (NSF) and the United Kingdom Research Councils (RCUK) have entered a five-year agreement, which went into effect last week, to abide by the same principals in meting out research grants. Times Higher Education noted that the funds are subject to limitations set by the US federal government, including restrictions on political science “projects that are deemed to be vital to national security or to furthering US economic interests,” THE reported. “The [NSF] is reportedly still considering how to interpret this rule.”

The pact, which affects proposals for behavioral and economic research projects between US and UK collaborators, lets researchers apply to just one agency—the one that funds the majority of the research—rather than having to apply to both. “This agreement not only strengthens the existing valuable research links between the U.K. and the U.S., but by avoiding ‘double jeopardy’ in funding applications, it removes some of the barriers facing international research collaboration,” said Paul Boyle, RCUK's international champion, in a press release.

But the agreement evidently subjects these international collaborations to US political will, which can impact research funding. Boyle pointed out in an article in Science last month that a proposed bill would cut out health economics research at the National Institutes of Health (NIH), ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery